Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease

References

• GOLDGlobal Strategy for the Diagnosis, Management, and Prevention of COPD (Updated 2015)Global Initiative for Chronic Obstructive Lung Disease2015 Available from: http://goldcopd.org/Accessed September 14, 2016
   Google Scholar
• WHOThe Global Burden of Disease (2004 Update)GenevaWorld Health Organization2008
   Google Scholar
• WHOGlobal Health Estimates Summary Tables: Deaths by Cause, Age and Sex by Various Regional GroupingGenevaWorld Health Organization2013
   Google Scholar
• KranenburgARWillems-WidyastutiAMooriWJEnhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary diseaseAm J Clin Pathol2006126572573517111536
   PubMed Web of Science ®Google Scholar
• AgustiAEdwardsLDRennardSIPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePloS One201275e3748322624038
   PubMed Web of Science ®Google Scholar
• LoskutoffDJvan MourikJAEricksonLALawrenceDDetection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cellsProc Natl Acad Sci U S A19838010295629606574465
   PubMed Web of Science ®Google Scholar
• SimpsonAJBoothNAMooreNRBennettBDistribution of plasminogen activator inhibitor (PAI-1) in tissuesJ Clin Pathol19914421391431864986
   PubMed Web of Science ®Google Scholar
• HaHOhEYLeeHBThe role of plasminogen activator inhibitor 1 in renal and cardiovascular diseasesNat Rev Nephrol20095420321119322185
   PubMed Web of Science ®Google Scholar
• DaciEVerstuyfAMoermansKBouillonRCarmelietGMice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiencyJ Bone Miner Res20001581510151610934649
   PubMed Web of Science ®Google Scholar
• LyonCJHsuehWAEffect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular diseaseAm J Med2003115Suppl 8A62s68s14678868
   PubMed Web of Science ®Google Scholar
• SchuligaMWestallGXiaYStewartAGThe plasminogen activation system: new targets in lung inflammation and remodelingCurr Opin Pharmacol201313338639323735578
   PubMed Web of Science ®Google Scholar
• Del RossoMMargheriFSerratiSChillaALaurenzanaAFibbiGThe urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulationCurr Pharm Des201117191924194321711238
   PubMed Web of Science ®Google Scholar
• ToMTakagiDAkashiKSputum plasminogen activator inhibitor-1 elevation by oxidative stress-dependent nuclear factor-kappaB activation in COPDChest2013144251552123558707
   PubMed Web of Science ®Google Scholar
• XiaoWHsuYPIshizakaAKirikaeTMossRBSputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammationChest200512842316232616236890
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• DeclerckPJGilsAThree decades of research on plasminogen activator inhibitor-1: a multifaceted serpinSemin Thromb Hemost201339435636423504606
   PubMed Web of Science ®Google Scholar
• KotaniISatoAHayakawaHUranoTTakadaYTakadaAIncreased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosisThromb Res19957764935047624837
   PubMed Web of Science ®Google Scholar
• ChoSKangJLyttleCAssociation of elevated plasminogen activator inhibitor 1 levels with diminished lung function in patients with asthmaAnn Allergy Asthma Immunol2011106537137721530867
   PubMed Web of Science ®Google Scholar
• BhandaryYPShettySKMarudamuthuASPlasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A virus infection-induced lung injuryPloS One2015105e012318725932922
   PubMed Web of Science ®Google Scholar
• AgustiAGNogueraASauledaJSalaEPonsJBusquetsXSystemic effects of chronic obstructive pulmonary diseaseEur Respir J200321234736012608452
   PubMed Web of Science ®Google Scholar
• EickhoffPValipourAKissDDeterminants of systemic vascular function in patients with stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008178121211121818836149
   PubMed Web of Science ®Google Scholar
• de TorresJPCordoba-LanusELopez-AguilarCC-reactive protein levels and clinically important predictive outcomes in stable COPD patientsEur Respir J200627590290716455829
   PubMed Web of Science ®Google Scholar
• RenWWangZHuaFZhuLPlasminogen activator inhibitor-1 regulates LPS-induced TLR4/MD-2 pathway activation and inflammation in alveolar macrophagesInflammation201538138439325342286
   PubMed Web of Science ®Google Scholar
• ChenCNanBLinPYaoQC-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cellsThromb Res2008122112513317949793
   PubMed Web of Science ®Google Scholar
• HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med2004350262645265315215480
   PubMed Web of Science ®Google Scholar
• PainMBermudezOLacostePTissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotypeEur Respir Rev20142313111813024591669
   PubMedGoogle Scholar
• WoessnerJFJrMatrix metalloproteinases and their inhibitors in connective tissue remodelingFASEB J199158214521541850705
   PubMed Web of Science ®Google Scholar
• BaratelliFEHeuze-Vourc’hNKrysanKProstaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrixJ Immunol200417395458546615494493
   PubMed Web of Science ®Google Scholar
• HigashimotoYYamagataYIwataTIncreased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patientsEur Respir J200525588589015863647
   PubMed Web of Science ®Google Scholar
• LinderRRonmarkEPourazarJBehndigABlombergALindbergASerum metalloproteinase-9 is related to COPD severity and symptoms – cross-sectional data from a population based cohort-studyRespir Res20151612825849664
   PubMed Web of Science ®Google Scholar
• WangQWangYZhangYZhangYXiaoWThe role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary diseaseRespir Res2013146723806081
   PubMed Web of Science ®Google Scholar
• MiyamotoSHattoriNSenooTIntra-airway administration of small interfering RNA targeting plasminogen activator inhibitor-1 attenuates allergic asthma in miceAm J Physiol Lung Cell Mol Physiol20113016L908L91621926267
   PubMed Web of Science ®Google Scholar